We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

13 hedge funds and large institutions have $4.39M invested in Summit Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0.05% more ownership

Funds ownership: 1.66% → 1.71% (+0.05%)

7% less funds holding

Funds holding: 14 → 13 (-1)

8% less capital invested

Capital invested by funds: $4.76M → $4.39M (-$368K)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$125K
2
JMPWA
JP Morgan Private Wealth Advisors
California
+$80.4K
3
VF
Virtu Financial
New York
+$26.6K
4
ASN
Advisory Services Network
Georgia
+$11.3K
5
Morgan Stanley
Morgan Stanley
New York
+$9.35K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$69.3K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$47K
3
Wells Fargo
Wells Fargo
California
-$4K
4
UBS Group
UBS Group
Switzerland
-$2K
5
LFG
Larson Financial Group
Missouri
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPU
1
Lansdowne Partners (UK)
United Kingdom
$2.56M – – –
PC
2
Polar Capital
United Kingdom
$480K – – –
Morgan Stanley
3
Morgan Stanley
New York
$374K +$9.35K +5,818 +3%
Bank of New York Mellon
4
Bank of New York Mellon
New York
$347K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$304K +$125K +77,728 +69%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$208K -$69.3K -43,073 -25%
JMPWA
7
JP Morgan Private Wealth Advisors
California
$80K +$80.4K +50,000 New
VF
8
Virtu Financial
New York
$26K +$26.6K +16,540 New
ASN
9
Advisory Services Network
Georgia
$11K +$11.3K +7,000 New
Deutsche Bank
10
Deutsche Bank
Germany
$3K +$2.83K +1,761 +881%
Group One Trading
11
Group One Trading
Illinois
$1K – – –
PFBT
12
Parkside Financial Bank & Trust
Missouri
$1K – – –
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
– -$47K -26,491 Closed
Wells Fargo
14
Wells Fargo
California
– -$4K -2,000 Closed
UBS Group
15
UBS Group
Switzerland
– -$2K -1,015 Closed
LFG
16
Larson Financial Group
Missouri
– -$1K -654 Closed

SMMT Hedge Fund Activity: Q4 2019 in Review

13 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q4 2019, worth a combined $4.39M — down 7.7% from $4.76M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SMMT and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $125K. The largest seller was Acadian Asset Management, cutting an estimated $69.3K.

  • 13 institutional investors held Summit Therapeutics (SMMT) as of Q4 2019, down from 14 in Q3 2019.
  • Funds reported $4.39M of Summit Therapeutics stock for Q4 2019, down 7.7% quarter-over-quarter.
  • 3 funds opened new Summit Therapeutics positions in Q4 2019 and 4 closed out, a net change of -1 holder.
  • The largest Summit Therapeutics buyer in Q4 2019 was Renaissance Technologies, an estimated $125K added.
  • The largest Summit Therapeutics seller in Q4 2019 was Acadian Asset Management, an estimated $69.3K sold.

Based on aggregated 13F filings for Q4 2019.